Carasent
23.55 SEK
+0.21 %
1,643 following
CARA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Carasent
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 50.8 | 67.7 | 141.0 | 207.9 | 242.3 | 267.7 | 343.8 |
| growth-% | 33.2 % | 108.2 % | 47.5 % | 16.6 % | 10.5 % | 28.4 % | |
| EBITDA | 12.6 | 15.4 | 33.9 | 34.8 | -26.4 | 6.4 | 71.9 |
| EBIT | 4.8 | 3.3 | 9.9 | -1.4 | -77.0 | -53.0 | 9.4 |
| Profit before taxes | 4.4 | -32.8 | 3.8 | 36.1 | -49.7 | -44.6 | 30.6 |
| Net income | 3.4 | -35.2 | 0.7 | 33.2 | -46.1 | -41.1 | 34.7 |
| EPS | 0.08 | -0.78 | 0.01 | 0.42 | -0.64 | -0.56 | 0.50 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 1.83 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | -0.0 % | 0.0 % | 0.0 % | -287.5 % | -0.0 % | 0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 24.8 % | 22.8 % | 24.1 % | 16.8 % | -10.9 % | 2.4 % | 20.9 % |
| EBIT-% | 9.3 % | 4.9 % | 7.0 % | -0.7 % | -31.8 % | -19.8 % | 2.7 % |
| ROE | 3.5 % | -9.1 % | 0.1 % | 2.5 % | -4.9 % | -4.7 % | 4.3 % |
| ROI | 2.3 % | -7.2 % | 0.0 % | 2.3 % | -4.2 % | -3.9 % | 3.7 % |